INVESTMENTS - RELATED PARTIES (Details 1) - USD ($)	3 Months Ended	9 Months Ended		12 Months Ended
	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Fair value of derivative instruments issued by AVLP	$ (165,840)	$ 5,773	$ (1,112,665)
Avalanche International Corp. ("AVLP") and Alzamend Neuro, Inc. ("Alzamend") [Member]
Investment in convertible promissory note of Alzamend		50,000
Investment in common stock of AVLP and Alzamend		587,686		558,938
Avalanche International Corp. ("AVLP") and Alzamend Neuro, Inc. ("Alzamend") [Member] | 8% Convertible Promissory Note [Member]
Balance at beginning		6,540,720
Investment in convertible promissory notes of AVLP		478,506
Investment in convertible promissory note of Alzamend		38,128
Investment in common stock of AVLP and Alzamend
Investment in warrants of Alzamend
Fair value of derivative instruments issued by AVLP
Unrealized loss in derivative instruments of AVLP
Unrealized loss in common stock of AVLP and Alzamend
Accretion of discount		1,968
Balance at end		7,059,322		6,540,720
Avalanche International Corp. ("AVLP") and Alzamend Neuro, Inc. ("Alzamend") [Member] | Warrants and Common Stock [Member]
Balance at beginning		2,128,224
Investment in convertible promissory notes of AVLP
Investment in convertible promissory note of Alzamend
Investment in common stock of AVLP and Alzamend		12,884
Investment in warrants of Alzamend		11,872
Fair value of derivative instruments issued by AVLP		80,076
Unrealized loss in derivative instruments of AVLP		1,080,034
Unrealized loss in common stock of AVLP and Alzamend		25,176
Accretion of discount
Balance at end		3,338,266		2,128,224
Avalanche International Corp. ("AVLP") and Alzamend Neuro, Inc. ("Alzamend") [Member]
Balance at beginning		8,668,944
Investment in convertible promissory notes of AVLP		478,506
Investment in convertible promissory note of Alzamend		38,128
Investment in common stock of AVLP and Alzamend		12,884
Investment in warrants of Alzamend		11,872
Fair value of derivative instruments issued by AVLP		80,076
Unrealized loss in derivative instruments of AVLP		1,080,034
Unrealized loss in common stock of AVLP and Alzamend		25,176
Accretion of discount		1,968
Balance at end		$ 10,397,588		$ 8,668,944